United States Transfection Technologies Market to Reach US$ 700.7 Million by 2032, Impelled by the Growing Demand for Genetic Research and Biopharmaceutical Development

August 21, 2023 | Healthcare

According to the latest report by IMARC Group, titled “United States Transfection Technologies Market Report by Product Type (Reagent, Instrument, and Others), Application (Therapeutic Delivery, Bio-Medical Research, Protein Production, and Others), Transfection Method (Lipofection, Electroporation, Nucleofection, Cotransfection, Cationic Lipid Transfection, In-Vivo Transfection, and Others), Technology (Physical Transfection, Biochemical Based Transfection, Viral-Vector Based Transfection), End User (Research Centers and Academic Institutes, Hospitals and Clinics, Pharmaceutical and Biotechnology Companies, and Others), and Region 2024-2032,” the United States transfection technologies market size reached US$ 386.3 Million in 2023. Transfection technology is a vital laboratory technique in molecular biology and biotechnology research. It introduces exogenous genetic material into eukaryotic cells, such as deoxyribonucleic acid (DNA) or ribonucleic acid (RNA), enabling scientists to study gene function, protein expression, cellular processes, and genetic modifications. It is utilized in various scientific fields, including gene function studies, protein expression for research or therapeutic purposes, disease research, cell line development, and drug screening. Transfection technology is applied to various cell types and biological systems allowing researchers to customize experiments by selecting specific genes or genetic elements to introduce into cells, and the technique offers both temporary and stable genetic modifications depending on the method used. The speed and efficiency of transfection allows for rapid manipulation of cell genetics, yielding quicker results than other genetic engineering approaches.

United States Transfection Technologies Market Trends:

The increasing demand for transfection technology as the understanding of genetics and molecular biology increases is one of the major factors driving the market growth. Additionally, the growing application of transfection technologies as researchers and biotechnologists rely on it to study gene function, protein expression, and cellular processes, leading to significant breakthroughs in various scientific fields, is creating a positive outlook for the market. Moreover, the rising prevalence of infectious diseases in the US, such as bacterial infections, necessitates the development of effective antibiotics enabling the introduction of antimicrobial genes or genetic constructs into cells to combat drug-resistant pathogens, is positively impacting the market growth. In addition to this, the growing application of these technologies for modifying cells before reintroducing them into patients, enhancing the therapeutic potential with cell-based therapies, such as CAR-T cell therapy, is supporting the market growth. Furthermore, rapid technological advancements in transfection methods and delivery systems that have made the process more efficient, reliable, and accessible are propelling the market growth. In line with this, the increasing utilization of these technologies in delivering therapeutic genes and molecules to target cancer cells and supporting precision medicine approaches tailored to individual patient profiles are providing remunerative growth opportunities. Besides this, the growing product popularity in the production of recombinant proteins used in therapeutic applications is favoring the market growth. Apart from this, the widespread application of transfection technology in the agricultural sector to engineer crops and improve their traits, such as disease resistance, nutritional content, and yield, and the increasing global demand for sustainable and enhanced crop production is providing a considerable boost to the market growth. Looking forward, the market value is projected to reach US$ 700.7 Million by 2032, expanding at a CAGR of 6.63% during 2024-2032.

Market Summary:

  • Based on the product type, the market has been segmented into reagents, instruments and others.
  • On the basis of the application, the market is divided into therapeutic delivery, bio-medical research, protein production and others.
  • Based on transfection method, the market has been categorized into lipofection, electroporation, nucleofection, cotransfection, cationic lipid transfection, in-vivo transfection and others.
  • On the basis of technology, the market has been segmented into physical transfection, bio-chemical based transfection and viral-vector based transfection.
  • Based on the end-user, the market has been categorized into research centers and academic institutes, hospitals and clinics, pharmaceutical and biotechnology companies and others.
  • Region-wise, the market has been segmented into Northeast, Midwest, South and West.
  • The competitive landscape of the market has also been examined along with the profiles of the key players.

Report Scope:

Report Features Details
Base Year of the Analysis 2023
Historical Period 2018-2023
Forecast Period 2024-2032
Units US$ Million
Segment Coverage Product Type, Application, Transfection Method, Technology, End User, Region
Region Covered Northeast, Midwest, South, West
Customization Scope 10% Free Customization
Report Price and Purchase Option Single User License: US$ 3699
Five User License: US$ 4699
Corporate License: US$ 5699
Post-Sale Analyst Support 10-12 Weeks
Delivery Format PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact Us:

134 N 4th St.
Brooklyn, NY 11249, USA
Email: Sales@imarcgroup.com
Americas:- +1 631 791 1145 | Africa and Europe :- +44-753-713-2163 | Asia: +91-120-433-0800

Need more help?

  • Speak to our experienced analysts for insights on the current market scenarios.
  • Include additional segments and countries to customize the report as per your requirement.
  • Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
  • For further assistance, please connect with our analysts.
United States Transfection Technologies Market to Reach US$ 700.7 Million by 2032, Impelled by the Growing Demand for Genetic Research and Biopharmaceutical Development
Purchase options

Benefits of Customization

Personalize this research

Triangulate with your data

Get data as per your format and definition

Gain a deeper dive into a specific application, geography, customer, or competitor

Any level of personalization

Get in Touch With Us

Phone: +1-631-791-1145


Phone: +91-120-433-0800


Phone: +44-753-714-6104

Email: sales@imarcgroup.com

Client Testimonials

Aktive Services

IMARC made the whole process easy. Everyone I spoke with via email was polite, easy to deal with, kept their promises regarding delivery timelines and were solutions focused. From my first contact, I was grateful for the professionalism shown by the whole IMARC team. I recommend IMARC to all that need timely, affordable information and advice. My experience with IMARC was excellent and I can not fault it.

Read More
Greenfish S.A.

The IMARC team was very reactive and flexible with regard to our requests. A very good overall experience. We are happy with the work that IMARC has provided, very complete and detailed. It has contributed to our business needs and provided the market visibility that we required

Read More
Colruyt Group

We were very happy with the collaboration between IMARC and Colruyt. Not only were your prices competitive, IMARC was also pretty fast in understanding the scope and our needs for this project. Even though it was not an easy task, performing a market research during the COVID-19 pandemic, you were able to get us the necessary information we needed. The IMARC team was very easy to work with and they showed us that it would go the extra mile if we needed anything extra

Read More

Last project executed by your team was as per our expectations. We also would like to associate for more assignments this year. Kudos to your team.

Read More
Zee Media Corp. Ltd.

We would be happy to reach out to IMARC again, if we need Market Research/Consulting/Consumer Research or any associated service. Overall experience was good, and the data points were quite helpful.

Read More
Arabian Plastic Manufacturing Company Ltd.

The figures of market study were very close to our assumed figures. The presentation of the study was neat and easy to analyse. The requested details of the study were fulfilled. My overall experience with the IMARC Team was satisfactory.

Read More
Sumitomo Corporation

The overall cost of the services were within our expectations. I was happy to have good communications in a timely manner. It was a great and quick way to have the information I needed.

Read More
Hameln Rds

My questions and concerns were answered in a satisfied way. The costs of the services were within our expectations. My overall experience with the IMARC Team was very good.

Read More
Quality Consultants BV

I agree the report was timely delivered, meeting the key objectives of the engagement. We had some discussion on the contents, adjustments were made fast and accurate. The response time was minimum in each case. Very good. You have a satisfied customer.

Read More
TATA Advanced Systems Limited

We would be happy to reach out to IMARC for more market reports in the future. The response from the account sales manager was very good. I appreciate the timely follow ups and post purchase support from the team. My overall experience with IMARC was good.

Read More

IMARC was a good solution for the data points that we really needed and couldn't find elsewhere. The team was easy to work, quick to respond, and flexible to our customization requests.

Read More